Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
NCT06988605
This study is recruiting at 33 US sites in 17 states, according to its ClinicalTrials.gov record last updated .
Summary
The main aim of the study is to assess real-world effectiveness of nemolizumab in Atopic Dermatitis (AD) as measured by physician assessment and patient reported outcome (PRO) in clinical practice at Month 6.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Atopic Dermatitis
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 12 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Galderma R&D
- Last updated on ClinicalTrials.gov
- March 13, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Arizona · 3
- Galderma Investigational Site - 8535 · Phoenix, AZ
- Galderma Investigational Site 7060 · Phoenix, AZ
- Galdrma Investigational Site - 7077 · Phoenix, AZ
California · 2
- Galderma Investigational Site 8224 · Fremont, CA
- Galderma Investigational Site 8553 · Newport Beach, CA
Connecticut · 1
- Galderma Investigational Site 7059 · Fairfield, CT
Florida · 5
- Galderma Investigational Site 7063 · Cutler Bay, FL
- Galderma Investigational Site 7134 · Hollywood, FL
- Galderma Investigational Site 7078 · Miami, FL
- Galderma Investigational Site 7090 · St. Petersburg, FL
- Galderma Investigational Site 7054 · Tampa, FL
Illinois · 1
- Galderma Investigational Site 7058 · Chicago, IL
Indiana · 1
- Galderma Investigational Site 8142 · Indianapolis, IN
Maryland · 3
- Galderma Investigational Site 7098 · Columbia, MD
- Galderma Investigational Site 8012 · Glenn Dale, MD
- Galderma Investigational Site 7068 · Rockville, MD
Massachusetts · 2
- Galderma Investigational Site 7065 · Brighton, MA
- Galderma Investigationa Site 7104 · Milford, MA
Michigan · 1
- Galderma Investigational Site 7071 · Caledonia, MI
Missouri · 1
- Galderma Investigational Site 7057 · Lee's Summit, MO
Nevada · 1
- Galderma Investigational Site 8848 · Las Vegas, NV
New Hampshire · 1
- Galderma Investigational Site 7055 · Portsmouth, NH
New York · 4
- Galderma Investigational Site - Site 7080 · Auburn, NY
- Galderma Investigational Site # 7052 · East Syracuse, NY
- Galderma Investigational Site - 7051 · New York, NY
- Galderma Investigational Site 7109 · New York, NY
Ohio · 1
- Galderma Investigational Site 7081 · Dayton, OH
Oregon · 1
- Galderma Investigational Site 7073 · Gresham, OR
Texas · 4
- Galderma Investigational Site 7082 · Cedar Park, TX
- Galderma Investigational Site 8238 · Dallas, TX
- Galderma Investigational Site 7088 · Grapevine, TX
- Galderma Investigational Site 7069 · Sugar Land, TX
West Virginia · 1
- Galderma Investigational Site 8725 · Morgantown, WV
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.